Gabapentin Capsule
Product Images NDC 70010-927

9 FDA label images from Granules Pharmaceuticals Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70010-927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gaba-formula (Gaba Formula)

Gaba-formula (Gaba Formula)
A mathematical formula calculating creatinine clearance (CLCr), used to estimate kidney function. The formula is: [(140 - age in years) x weight in kilograms] divided by [72 x serum creatinine in mg/dL], multiplied by 0.85 for female patients.*
FDA Label Image

Gaba-structure (Gaba Structure)

Gaba-structure (Gaba Structure)
Chemical structure of gabapentin showing a cyclohexane ring attached to an amino group (CH2NH2) and a carboxymethyl group (CH2CO2H).*
FDA Label Image

Gaba-fig1 (Gaba Fig1)

Gaba-fig1 (Gaba Fig1)
A line graph comparing mean pain scores over 8 weeks between placebo and gabapentin 3600 mg/day treatments. The x-axis represents weeks from baseline to week 8, marking a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin group shows a steady decrease in pain score, while placebo remains relatively stable.*
FDA Label Image

Gaba-fig2 (Gaba Fig2)

Gaba-fig2 (Gaba Fig2)
A line graph showing the mean pain score over a 7-week period for Gabapentin versus placebo. The x-axis represents weeks including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. The graph compares placebo with Gabapentin doses of 1800 mg/day and 2400 mg/day, illustrating changes in mean pain scores over time.*
FDA Label Image

Gaba-fig3 (Gaba Fig3)

Gaba-fig3 (Gaba Fig3)
A bar chart titled 'Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) treatment groups in two studies. It shows the percentage of responders, with GBP groups having higher response rates (29% to 34%) than placebo groups (12% to 14%) across different dosages.*
FDA Label Image

Gaba-fig4 (Gaba Fig4)

Gaba-fig4 (Gaba Fig4)
A scatter plot chart comparing the percentage difference against daily doses of gabapentin (mg) across three studies (Study a, Study b, Study c). The x-axis represents daily dose in mg, ranging from 600 to 1800 mg. The y-axis shows percentage difference from 2% to 22%. Data points for each study are marked with different symbols and are labeled with letters a, b, or c.*
FDA Label Image

Gaba-100mg-100s-label (Gaba 100mg 100s Label)

Gaba-100mg-100s-label (Gaba 100mg 100s Label)
Label for Gabapentin Capsules, USP 100 mg, 100 count, oral capsule manufactured by Granules India Limited and labeled by Granules Pharmaceuticals Inc. The label includes storage instructions, pharmacy dispensing notes, and a barcode. The product is made in India and distributed from Chantilly, VA.*
FDA Label Image

Gaba-300mg-100s-label (Gaba 300mg 100s Label)

Gaba-300mg-100s-label (Gaba 300mg 100s Label)
Gabapentin Capsules, USP, 300 mg oral capsules, 100 count package. The label displays the NDC 70010-927-01 and states the product is manufactured by Granules India Limited and labeled for Granules Pharmaceuticals Inc., Chantilly, VA. Storage instructions and dispensing information are included along with two barcodes.*
FDA Label Image

Gaba-400mg-100s-label (Gaba 400mg 100s Label)

Gaba-400mg-100s-label (Gaba 400mg 100s Label)
Gabapentin Capsules, USP 400 mg oral capsules packaging label displaying NDC 70010-928-01. The label indicates a bottle of 100 capsules, with storage instructions and manufacturer details for Granules Pharmaceuticals Inc. It includes directions to dispense a Medication Guide and states the capsules are made in India by Granules India Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.